Somerville, MA, United States of America

Namita Bisaria

This inventor holds 3 USPTO granted patents and 12 published patent applications. Top assignees: Myeloid Therapeutics, Inc., Children's Medical Center Corporation, Ganna Bio, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Namita Bisaria. Retrieved from https://idiyas.com/inventor/namita-bisaria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Namita Bisaria - Revolutionizing Technology

Introduction: Namita Bisaria, a brilliant inventor based in Somerville, MA, is making waves in the tech industry with her innovative creations and forward-thinking approach.

Latest Patents: Namita Bisaria holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and ingenuity.

Career Highlights: With a background in engineering and a passion for problem-solving, Namita has successfully brought several cutting-edge inventions to life, earning her a reputation as a trailblazer in the industry.

Collaborations: Throughout her career, Namita has collaborated with top research institutions, leading companies, and visionary inventors, fostering a culture of innovation and collaboration in all her projects.

Conclusion: Namita Bisaria's dedication to pushing the boundaries of technology and her relentless pursuit of excellence continue to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…